Llueca, A.; Ibañez, M.V.; Cascales, P.; Gil-Moreno, A.; Bebia, V.; Ponce, J.; Fernandez, S.; Arjona-Sanchez, A.; Muruzabal, J.C.; Veiga, N.;
et al. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study. Cancers 2023, 15, 4271.
https://doi.org/10.3390/cancers15174271
AMA Style
Llueca A, Ibañez MV, Cascales P, Gil-Moreno A, Bebia V, Ponce J, Fernandez S, Arjona-Sanchez A, Muruzabal JC, Veiga N,
et al. Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study. Cancers. 2023; 15(17):4271.
https://doi.org/10.3390/cancers15174271
Chicago/Turabian Style
Llueca, Antoni, Maria Victoria Ibañez, Pedro Cascales, Antonio Gil-Moreno, Vicente Bebia, Jordi Ponce, Sergi Fernandez, Alvaro Arjona-Sanchez, Juan Carlos Muruzabal, Nadia Veiga,
and et al. 2023. "Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study" Cancers 15, no. 17: 4271.
https://doi.org/10.3390/cancers15174271
APA Style
Llueca, A., Ibañez, M. V., Cascales, P., Gil-Moreno, A., Bebia, V., Ponce, J., Fernandez, S., Arjona-Sanchez, A., Muruzabal, J. C., Veiga, N., Diaz-Feijoo, B., Celada, C., Gilabert-Estelles, J., Aghababyan, C., Lacueva, J., Calero, A., Segura, J. J., Maiocchi, K., Llorca, S.,
... on behalf of Spain GOG and GECOP Working Group.
(2023). Neoadjuvant Chemotherapy plus Interval Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy (NIHIPEC) in the Treatment of Advanced Ovarian Cancer: A Multicentric Propensity Score Study. Cancers, 15(17), 4271.
https://doi.org/10.3390/cancers15174271
